Nancy Wells, NP
Women's Health · Bossier City, LANPI 1891709978
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,102 of the $46,623 with a category attached, or 90.3%. Organon accounts for 83.0% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2022 at $17,051 and has fallen 77.6% since, to $3,813 in 2025. Among women's health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $185.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$39K
- Merck$5K
- Daiichi Sankyo Inc.$551
- AbbVie$500
- Astellas Pharma US Inc$336
- Evofem Biosciences, Inc.$224
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$42,10290%
- Travel & lodging$7392%
- Food & beverage$3,6848%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 80 | $38,682 |
| Merck | 10 | $4,758 |
| Daiichi Sankyo Inc. | 29 | $551 |
| AbbVie | 28 | $500 |
| Astellas Pharma US Inc | 10 | $336 |
| Evofem Biosciences, Inc. | 15 | $224 |
| Pfizer | 12 | $190 |
| Mayne Pharma Commercial LLC | 8 | $160 |
| Aspira Women's Health Inc | 2 | $152 |
| Exeltis, USA Inc. | 10 | $152 |
| Sumitomo Pharma America, Inc. | 7 | $142 |
| Sage Therapeutics, LLC | 5 | $90 |
| Myriad Women's Health, Inc. | 1 | $69 |
| Dexcom, Inc. | 2 | $65 |
| Millicent US Inc | 4 | $64 |
| Novo Nordisk | 3 | $61 |
| Amgen | 4 | $58 |
| Hologic Sales And Service, LLC | 2 | $51 |
| Lupin Inc. | 3 | $41 |
| Shield Therapeutics Inc | 2 | $37 |
| Scynexis, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Vertex | 2 | $27 |
| Davol Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$39,585
- INJECTAFER$125
- Veozah$125
How this compares
$46,623 in reported general payments places this provider in the 95th percentile of 128 women's health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 41 | $1,796 |
| Estradiol (Once Weekly)Estradiol | 16 | $1,130 |
| Clobetasol Propionate | 16 | $160 |
| Fluconazole | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other women's health in Bossier City
- Lauren FordBossier City$3K
- Thresa CaughmanBossier City$3K
- Christina LeachBossier City$563
- Amanda HayesShreveport$51K
- Ann JoplingMonroe$16K
- Kendra Joseph-RodgersNew Orleans$10K
- Aundria CannonLafayette$5K
- Jordan ForsthoffLafayette$5K
- Jennifer MillerMonroe$4K
- Alysha HinsonShreveport$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.